What does Pharmacie de Lesve do?

Pharmacie de Lesve is a pharmacy in Profondeville. Private Limited, started on 30 December 2016, 1 establishment.

What is the address of Pharmacie de Lesve?

The registered office of Pharmacie de Lesve is located at Rue du Centre(LV) 8, 5170 Profondeville.

Is Pharmacie de Lesve still active?

Yes. According to the CBE (19 September 2026) Pharmacie de Lesve is active, legal situation “Normale toestand”, started on 30 December 2016.

Is Pharmacie de Lesve registered on Peppol?

Yes, Pharmacie de Lesve is registered on the Peppol network with ID 0208:0668615555.

What is the enterprise number of Pharmacie de Lesve?

The enterprise number of Pharmacie de Lesve is BE0668615555.

When was Pharmacie de Lesve founded?

Pharmacie de Lesve was founded on 30 December 2016.

Is Pharmacie de Lesve a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 December 2016; 5 annual accounts filed, latest fiscal year 2025.

How much profit did Pharmacie de Lesve make in 2025?

Pharmacie de Lesve posted a profit after taxes of € 116,187 in financial year 2025.

What is the revenue of Pharmacie de Lesve?

As a small company, Pharmacie de Lesve is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 441,972.

How much does an employee at Pharmacie de Lesve earn?

The average wage cost per full-time employee at Pharmacie de Lesve was € 51,200 in 2025: staff costs of € 194,715 for 3.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie de Lesve have?

According to the 2025 annual accounts, Pharmacie de Lesve has 3.8 full-time equivalents (FTE).

Pharmacie de Lesve (Private Limited) - Profondeville

Dossier Pharmacie de Lesve, printed on 19 September 2026 from databakkes.be/en/0668615555/pharmacie-de-lesve. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie de Lesve from Profondeville, company number BE0668615555, closed financial year 2025 with a result of € 116,187 after tax. For that financial year Pharmacie de Lesve recorded a gross margin of € 441,972 and equity of € 321,622. Compared with financial year 2024, the result moved from € 91,653 to € 116,187. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Healthy

€ 321,622

▼ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 116,187

▲ 27% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 186,167

▲ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 231,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

3.8

▲ 0.9 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 194,715

▲ 13% vs 2024

€ 51,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 30,220

▲ 87% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 398,550

▼ 13% vs 2024

€ 52,653 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 125,674

▲ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,569

▲ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 399,012 Gross margin 2022: € 399,012 First fiscal year in the series	€ 357,500 Gross margin 2023: € 357,500 ▼ 10% vs 2022 (€ 399,012) Unfavourable step	€ 388,542 Gross margin 2024: € 388,542 ▲ 9% vs 2023 (€ 357,500) Favourable step	€ 441,972 Gross margin 2025: € 441,972 ▲ 14% vs 2024 (€ 388,542) Favourable step	▲ 14%
Profit after taxes	€ 124,070 Profit after taxes 2022: € 124,070 First fiscal year in the series	€ 74,268 Profit after taxes 2023: € 74,268 ▼ 40% vs 2022 (€ 124,070) Unfavourable step	€ 91,653 Profit after taxes 2024: € 91,653 ▲ 23% vs 2023 (€ 74,268) Favourable step	€ 116,187 Profit after taxes 2025: € 116,187 ▲ 27% vs 2024 (€ 91,653) Favourable step	▲ 27%
Equity	€ 331,015 Equity 2022: € 331,015 First fiscal year in the series	€ 381,283 Equity 2023: € 381,283 ▲ 15% vs 2022 (€ 331,015) Favourable step	€ 436,936 Equity 2024: € 436,936 ▲ 15% vs 2023 (€ 381,283) Favourable step	€ 321,622 Equity 2025: € 321,622 ▼ 26% vs 2024 (€ 436,936) Unfavourable step	▼ 26%
Total debts	€ 741,583 Total debts 2022: € 741,583 First fiscal year in the series	€ 667,943 Total debts 2023: € 667,943 ▼ 10% vs 2022 (€ 741,583) Favourable step	€ 626,003 Total debts 2024: € 626,003 ▼ 6% vs 2023 (€ 667,943) Favourable step	€ 791,088 Total debts 2025: € 791,088 ▲ 26% vs 2024 (€ 626,003) Unfavourable step	▲ 26%
Cash	€ 287,183 Cash 2022: € 287,183 First fiscal year in the series	€ 172,149 Cash 2023: € 172,149 ▼ 40% vs 2022 (€ 287,183) Unfavourable step	€ 182,550 Cash 2024: € 182,550 ▲ 6% vs 2023 (€ 172,149) Favourable step	€ 186,167 Cash 2025: € 186,167 ▲ 2% vs 2024 (€ 182,550) Favourable step	▲ 2%
Retained profit	€ 324,815 Retained profit 2022: € 324,815 First fiscal year in the series	€ 375,083 Retained profit 2023: € 375,083 ▲ 15% vs 2022 (€ 324,815) Favourable step	€ 430,736 Retained profit 2024: € 430,736 ▲ 15% vs 2023 (€ 375,083) Favourable step	€ 315,422 Retained profit 2025: € 315,422 ▼ 27% vs 2024 (€ 430,736) Unfavourable step	▼ 27%
Dividend	€ 24,000 Dividend 2022: € 24,000 First fiscal year in the series	€ 24,000 Dividend 2023: € 24,000 Unchanged (€ 24,000) Unchanged	€ 36,000 Dividend 2024: € 36,000 ▲ 50% vs 2023 (€ 24,000) Unchanged	€ 231,500 Dividend 2025: € 231,500 ▲ € 195,500 vs 2024 (€ 36,000) Unchanged	▲ € 195,500
Bank debt	€ 578,994 Bank debt 2022: € 578,994 First fiscal year in the series	€ 519,169 Bank debt 2023: € 519,169 ▼ 10% vs 2022 (€ 578,994) Favourable step	€ 458,539 Bank debt 2024: € 458,539 ▼ 12% vs 2023 (€ 519,169) Favourable step	€ 398,550 Bank debt 2025: € 398,550 ▼ 13% vs 2024 (€ 458,539) Favourable step	▼ 13%
Balance sheet total	€ 1,072,597 Balance sheet total 2022: € 1,072,597 First fiscal year in the series	€ 1,049,226 Balance sheet total 2023: € 1,049,226 ▼ 2% vs 2022 (€ 1,072,597) Unchanged	€ 1,062,939 Balance sheet total 2024: € 1,062,939 ▲ 1% vs 2023 (€ 1,049,226) Unchanged	€ 1,112,710 Balance sheet total 2025: € 1,112,710 ▲ 5% vs 2024 (€ 1,062,939) Unchanged	▲ 5%
Employees (FTE)	3 Employees (FTE) 2022: 3 First fiscal year in the series	2.6 Employees (FTE) 2023: 2.6 ▼ 0.4 vs 2022 (3) Unchanged	2.9 Employees (FTE) 2024: 2.9 ▲ 0.3 vs 2023 (2.6) Unchanged	3.8 Employees (FTE) 2025: 3.8 ▲ 0.9 vs 2024 (2.9) Unchanged	▲ 0.9

Key figures of Pharmacie de Lesve, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie de Lesve?

What happened at Pharmacie de Lesve in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 116,187 (▲ 27% vs 2024). Source: NBB ↗
Jan 1, 2017 New establishment in Profondeville. KBO
Dec 30, 2016 Start of the company according to the CBE. KBO

In short

From € 124,070 profit in 2022 to € 116,187 profit in 2025.

Paid € 138,010 in corporate taxes since 2022.

Best year ever: 2022, with € 124,070 profit.

On average € 116,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at Pharmacie de Lesve? We notify you, reason included.

Follow Pharmacie de Lesve

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit